These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21389866)

  • 21. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
    Sacchi A; Gasparri A; Curnis F; Bellone M; Corti A
    Cancer Res; 2004 Oct; 64(19):7150-5. PubMed ID: 15466213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
    Lu C; Kamat AA; Lin YG; Merritt WM; Landen CN; Kim TJ; Spannuth W; Arumugam T; Han LY; Jennings NB; Logsdon C; Jaffe RB; Coleman RL; Sood AK
    Clin Cancer Res; 2007 Jul; 13(14):4209-17. PubMed ID: 17634550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z; Strojan P
    Neoplasma; 1996; 43(2):93-7. PubMed ID: 8843969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.
    Robinson SP; Ludwig C; Paulsson J; Ostman A
    Int J Cancer; 2008 Apr; 122(7):1548-56. PubMed ID: 18033683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-alpha as angiogenesis inhibitor: learning from tumor models.
    Indraccolo S
    Autoimmunity; 2010 Apr; 43(3):244-7. PubMed ID: 20166871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
    Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
    Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally administered rapamycin, dacarbazine or both for treatment of human melanoma evaluated in severe combined immunodeficiency mice.
    Thallinger C; Skorjanec S; Soleiman A; Tzaneva S; Griss J; Rous W; Poeppl W; Weinlich G; Karimian-Teherani D; Joukhadar C
    Pharmacology; 2008; 82(3):233-8. PubMed ID: 18810248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
    Yang W; Li XY
    Chin Med J (Engl); 2005 Feb; 118(4):296-301. PubMed ID: 15740667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulator of G-protein signaling 5 regulates the shift from perivascular to parenchymal pericytes in the chronic phase after stroke.
    Roth M; Gaceb A; Enström A; Padel T; Genové G; Özen I; Paul G
    FASEB J; 2019 Aug; 33(8):8990-8998. PubMed ID: 31039042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure.
    Ferretti S; Allegrini PR; O'Reilly T; Schnell C; Stumm M; Wartmann M; Wood J; McSheehy PM
    Clin Cancer Res; 2005 Nov; 11(21):7773-84. PubMed ID: 16278399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
    Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells.
    Bondjers C; Kalén M; Hellström M; Scheidl SJ; Abramsson A; Renner O; Lindahl P; Cho H; Kehrl J; Betsholtz C
    Am J Pathol; 2003 Mar; 162(3):721-9. PubMed ID: 12598306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
    Jazowiecka-Rakus J; Jarosz M; Szala S
    Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
    Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
    Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.
    Dirkx AE; Oude Egbrink MG; Kuijpers MJ; van der Niet ST; Heijnen VV; Bouma-ter Steege JC; Wagstaff J; Griffioen AW
    Cancer Res; 2003 May; 63(9):2322-9. PubMed ID: 12727857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M
    Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate.
    Ogawa Y; Kawamura T; Furuhashi M; Tsukamoto K; Shimada S
    J Dermatol Sci; 2008 Sep; 51(3):190-9. PubMed ID: 18485676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a mouse model of pancreatic neuroendocrine tumors to find pericyte biomarkers of resistance to anti-angiogenic therapy.
    Franco M; Pàez-Ribes M; Cortez E; Casanovas O; Pietras K
    Horm Metab Res; 2011 Nov; 43(12):884-9. PubMed ID: 21960459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.